GGrantIndex
Sort

53,477 grants matching addiction

Biological And Biochemical Characterization Of Sigma Receptors

$1,139,116
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2019 · DA

Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder

$1,139,075
Andrew S Huhn · Johns Hopkins University · UG3 · FY2019 · DA

Florida Node of The Drug Abuse Clinical Trials Network

$1,139,016
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2008 · DA

Alternative Therapies for Alcohol and Drug Abuse

$1,138,441
Mc Lean Hospital (Belmont, Ma) · P01 · FY2005 · AT

Sex Differences and Progesterone Effects on Impulsivity, Smoking & Cocaine Abuse

$1,138,368
Marilyn E. Carroll · University Of Minnesota · P50 · FY2016 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$1,138,357
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2021 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$1,138,357
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2023 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$1,138,357
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2022 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$1,138,357
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2020 · DA

Clinical Trials Network: Pacific Northwest Node

$1,138,013
Dennis M Donovan · University Of Washington · U10 · FY2011 · DA

Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling

$1,137,985
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2024 · DA

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

$1,137,273
Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2022 · AA

Biomarker and Analytical Chemistry Core

$1,137,053
Dongxiao Sun · Pennsylvania State Univ Hershey Med Ctr · U54 · FY2023 · DA

Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose.

$1,136,636
Marisa Briones · Bdh Pharma, Llc · R44 · FY2022 · DA

Novel interventions to reduce stress induced non-homeostatic eating

$1,135,930
Elissa S. Epel · University Of California, San Francisco · U01 · FY2012 · HL

Potassium Channels and Dendritic Function in Hippocampal Pyramidal Neurons

$1,135,885
Dax A Hoffman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$1,135,271
James L. Sorensen · University Of California, San Francisco · U10 · FY2011 · DA

Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?

$1,134,658
Evan D Morris · Yale University · R01 · FY2019 · DA

Clinical development of mechanism-based lymphoma therapies

$1,134,609
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Clinical Trials Network Mid-Atlantic Collaborative Group

$1,134,513
Maxine L Stitzer · Johns Hopkins University · U10 · FY2013 · DA

Center for Adaptive Neurotechnologies

$1,134,512
Jonathan Rickel Wolpaw · Wadsworth Center · P41 · FY2018 · EB

Center for Adaptive Neurotechnologies

$1,134,495
Jonathan Rickel Wolpaw · Wadsworth Center · P41 · FY2017 · EB

CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE

$1,133,914
Temple University · P30 · FY2003 · DA

AACAP Physician Scientist Program in Substance Abuse

$1,133,676
Paula Riggs · American Academy-Child/Adolescent Psych · K12 · FY2006 · DA

AACAP Physician Scientist Program in Substance Abuse

$1,133,676
Paula Riggs · American Academy-Child/Adolescent Psych · K12 · FY2008 · DA